Sign in

You're signed outSign in or to get full access.

INTERFACE (TILE)

--

Earnings summaries and quarterly performance for INTERFACE.

Recent press releases and 8-K filings for TILE.

Interface, Inc. Amends and Restates Syndicated Facility Agreement
TILE
Debt Issuance
  • Interface, Inc. entered into a Third Amended and Restated Syndicated Facility Agreement on December 3, 2025, extending the maturity date of its revolving and term loan credit facilities from October 14, 2027 to December 3, 2030.
  • The company added a new term loan facility in an aggregate principal amount of $170 million, which was fully drawn at closing, and reduced its revolving credit facility from $300 million to $250 million.
  • At closing, the total indebtedness under the Agreement was approximately $205 million, with an estimated weighted average interest rate of 5.24%.
  • The Agreement includes financial covenants requiring a Consolidated Secured Net Leverage Ratio of no greater than 3.00:1.00 and a Consolidated Interest Coverage Ratio of no less than 2.25:1.00.
Dec 3, 2025, 10:21 PM
Interface announces Q3 2025 financial results
TILE
Earnings
Revenue Acceleration/Inflection
  • Interface reported Net Sales of $364.5 million for Q3 2025, an increase of 5.9% compared to Q3 2024, with year-to-date net sales reaching $1,037.5 million, up 5.8%.
  • Diluted EPS (GAAP) for Q3 2025 was $0.78, a 62.5% increase from Q3 2024, and year-to-date diluted EPS grew 39.6% to $1.55.
  • Adjusted EBITDA for Q3 2025 increased by 23.3% to $66.2 million, contributing to a year-to-date adjusted EBITDA of $168.1 million, up 17.6%.
  • The company significantly improved its Net Debt / Adjusted EBITDA ratio, reducing it to 0.6x as of Q3 2025, down from 1.1x in FY2024.
  • Interface maintains a diversified revenue base, with 61% from the Americas, 28% from EMEA, and 10% from APAC, and key customer segments including 45% Corporate Office and 20% Education (LTM Q3 2025).
Oct 31, 2025, 12:00 PM
Interface Inc. Reports Strong Q3 2025 Results and Raises Full-Year Guidance
TILE
Earnings
Guidance Update
New Projects/Investments
  • Interface Inc. reported strong Q3 2025 net sales of $364.5 million, an increase of 5.9% as reported and 4.2% on a currency-neutral basis compared to Q3 2024, exceeding expectations.
  • Profitability saw significant gains, with adjusted gross profit margin expanding by 208 basis points to 39.5% and adjusted earnings per share rising 27% to $0.61.
  • Growth was broad-based across regions and product categories, notably with global healthcare billings up 29% and nora rubber sales growing 20% in the quarter.
  • The company raised its full-year 2025 guidance, now projecting net sales of $1.375 to $1.390 billion and an adjusted gross profit margin of 38.5%.
  • Interface generated $76.7 million in operating cash flow and repurchased $0.7 million of common stock during the quarter, while planning increased capital expenditures for productivity and innovation in 2026.
Oct 31, 2025, 12:00 PM
Interface Announces Strong Q3 2025 Results and Raises Full-Year Guidance
TILE
Earnings
Guidance Update
New Projects/Investments
  • Interface reported strong Q3 2025 financial results, with net sales of $364.5 million, up 5.9% as reported and 4.2% currency-neutral year-over-year, exceeding expectations.
  • Adjusted gross profit margin expanded by 208 basis points to 39.5%, contributing to a 27% increase in adjusted earnings per share to $0.61 compared to Q3 2024.
  • The company raised its full-year 2025 net sales guidance to a range of $1.375 billion to $1.390 billion and anticipates an adjusted gross profit margin of 38.5%.
  • Growth was driven by the "One Interface" strategy, with global healthcare billings up 29% and nora rubber sales growing 20% in Q3 2025, alongside ongoing investments in automation and innovation.
Oct 31, 2025, 12:00 PM
Interface Reports Strong Q3 2025 Results and Raises Full-Year Guidance
TILE
Earnings
Guidance Update
Revenue Acceleration/Inflection
  • Interface (TILE) reported strong Q3 2025 results, with net sales reaching $364.5 million, an increase of 5.9% as reported and 4.2% on a currency-neutral basis, surpassing expectations.
  • Profitability significantly improved, with adjusted gross profit margin expanding by 208 basis points to 39.5% and adjusted earnings per share increasing 27% year-over-year to $0.61.
  • Growth was broad-based across segments and regions, highlighted by global healthcare billings up 29%, corporate office billings up 5%, and nora rubber sales growing 20% in the quarter. Consolidated currency-neutral orders also increased 2.4% year-over-year.
  • The company generated $76.7 million in operating cash flow and repurchased $0.7 million of common stock, ending the quarter with $482 million in liquidity and a net leverage ratio of 0.6 times.
  • Interface raised its full-year 2025 guidance, now projecting net sales between $1.375 billion and $1.390 billion and an adjusted gross profit margin of 38.5%.
Oct 31, 2025, 12:00 PM
Interface Reports Strong Q3 2025 Results and Raises Full-Year Guidance
TILE
Earnings
Guidance Update
Revenue Acceleration/Inflection
  • Interface reported Q3 2025 net sales of $364.5 million, an increase of 5.9% year-over-year, or 4.2% currency neutral.
  • GAAP earnings per diluted share for Q3 2025 were $0.78, a 62.5% increase, while Adjusted earnings per diluted share rose 27.1% to $0.61.
  • The company is raising its full fiscal year 2025 outlook for net sales to a range of $1.375 billion to $1.390 billion.
  • The "One Interface" strategy contributed to a 233 basis point expansion in gross profit margin due to favorable mix and manufacturing efficiencies.
Oct 31, 2025, 10:39 AM
Interface Reports Third Quarter 2025 Results
TILE
Earnings
Guidance Update
Revenue Acceleration/Inflection
  • Interface reported net sales of $364.5 million for the third quarter ended September 28, 2025, marking a 5.9% increase year-over-year. On a currency-neutral basis, net sales increased 4.2%.
  • GAAP earnings per diluted share for Q3 2025 increased 62.5% to $0.78, while Adjusted earnings per diluted share rose 27.1% to $0.61.
  • The company's "One Interface strategy" contributed to global billings growth across all regions and product categories, with a notable 29% increase in Healthcare and a 5% increase in Corporate Office.
  • Interface raised its full fiscal year 2025 outlook, now expecting net sales between $1.375 billion and $1.390 billion and an adjusted gross profit margin of 38.5% of net sales.
Oct 31, 2025, 9:30 AM